Schistosoma: Difference between revisions
From IDWiki
Schistosoma
m (Aidan moved page Schistosoma spp. (schistosomiasis) to Schistosoma species without leaving a redirect) |
No edit summary |
||
| Line 1: | Line 1: | ||
= ''Schistosoma'' spp. (schistosomiasis) = |
|||
== Definition == |
|||
* Infection with a species of the genus ''Schistosoma'' |
* Infection with a species of the genus ''Schistosoma'' |
||
| Line 40: | Line 36: | ||
* Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis |
* Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis |
||
{{DISPLAYTITLE:''Schistosoma'' species}} |
|||
== Further Reading == |
|||
[[Category:Parasites]] |
|||
Revision as of 11:29, 16 August 2019
- Infection with a species of the genus Schistosoma
Species
- S. mansoni: liver and gut
- S. haematobium: GU/pelvis
- S. japonicum: liver and gut
- S. mekongi: Mekong basin
Risk Factors
- Fresh water exposure in endemic countries
Clinical Presentation
Investigations
- Labs
- CBC, showing eosinophilia
- Schisto serology (only positive 6 weeks after infection)
- Egg detection in stool, urine, semen, or tissue biopsy
- Imaging
- Eggs can cause granulomatous disease in various organs
- Bladder polyps and obstruction may be seen on ultrasound
Management
- Acute
- Praziquantel 40mg/kg/d
- Can cause nausea, dizziness, and fever
- Praziquantel 40mg/kg/d
- Chronic
- Prevention
Prognosis
- Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis
References
- ^ Archana Asundi, Alina Beliavsky, Xing Jian Liu, Arash Akaberi, Guido Schwarzer, Zeno Bisoffi, Ana Requena-Méndez, Ian Shrier, Christina Greenaway. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(2):e236-e248. doi:10.1016/s2214-109x(18)30490-x.
- ^ Michelle K. Yong, Carolyn L. Beckett, Karin Leder, Beverley A. Biggs, Joseph Torresi, Daniel P. O’Brien. Long‐Term Follow‐Up ofSchistosomiasisSerology Post‐Treatment in Australian Travelers and Immigrants. Journal of Travel Medicine. 2010;17(2):89-93. doi:10.1111/j.1708-8305.2009.00379.x.
